Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By



Set Alert for Pharmaceuticals

US veterinary compounding companies to merge following acquisition

US veterinary drug compounding firms Wedgewood Pharmacy and Diamondback Drugs have agreed to a merger.

M&A Deals

Animal Pharm seeks freelance special reports writers

Animal Pharm is looking for new authors for its animal health industry reports team.

Policy & Regulation Companion Animals

Study outlines crossover potential for vet antiparasitics into human medicine

New research has outlined the potential of repurposing common veterinary antiparasiticides for the control of human vector-borne diseases.

Research Antiparasitics

ImmuCell overcomes majority of First Defense backlog

US firm Immucell has addressed a backlog of orders for its First Defense product line against calf scours.

Financial Results Pharmaceuticals

Boehringer, Jurox secure supplemental FDA approvals

Boehringer Ingelheim Vetmedica has gained a supplemental US approval for Cystorelin (gonadorelin), which is used in reproductive synchrony programs for cattle.

United States Boehringer Ingelheim Animal Health

EU Agriculture Committee backs new rules on medicated feed, AMR

Agriculture Committee members of the European Parliament (MEPs) have given the green light to new rules regarding medicated feed and antimicrobial resistance (AMR).

Policy & Regulation Antimicrobial resistance

KindredBio becomes commercial entity as Mirataz goes on sale

US pet therapeutics company Kindred Biosciences has become a commercial entity around six years after it was founded.

United States Kindred Biosciences

Animalcare to launch Cortacare in Q4, ahead of 16 more prioritized candidates

UK firm Animalcare has pencilled a fourth-quarter launch date for its recently-approved Cortacare canine dermatology product.

Generics Pharmaceuticals

Animal Ethics gains new indications for Tri-Solfen in Australia

Animal Ethics has extended the use of its Tri-Solfen pain relief product to calves through a new Australian approval.

Australia Bovine

Israeli shrimp disease start-up secures investment from Nutreco

Dutch animal nutrition business Nutreco has invested in young Israeli company ViAqua to aid development of a treatment that improves resistance to viral diseases in shrimp.

Nutreco Investments

Boehringer's Zactran, MSD's Bravecto secure Japanese extensions

Boehringer Ingelheim Animal Health has secured Japanese approval for Zactran (gamithromycin) as an antibiotic treatment of swine respiratory disease.

Japan Boehringer Ingelheim Animal Health

CannPal in Eurofins collaboration to expand cannabis therapeutic into cats

Australian firm CannPal Therapeutics has signed a research agreement with Eurofins Animal Health to develop a cannabis-derived pain therapeutic for cats.

Companion Animals Pharmaceuticals
See All